Literature DB >> 7862827

Behavioural evidence for "D-1-like" dopamine receptor subtypes in rat brain using the new isochroman agonist A 68930 and isoquinoline antagonist BW 737C.

S A Daly1, J L Waddington.   

Abstract

The full efficacy, high potency isochroman D-1 agonist A 68930 demonstrated greater than 220-fold selectivity for D-1 over D-2 receptors. A 68930 (0.06 and 0.25 mg/kg) readily induced intense grooming, together with vacuous chewing; these responses became less evident following higher doses (1.0 and 4.0 mg/kg) and sniffing became prominent. Intense grooming was blocked by three D-1 antagonists, the benzazepines SCH 23390 (0.01-1.0 mg/kg) and NNC-756 (0.01-1.0 mg/kg), and the isoquinoline BW 737C (0.2-5.0 mg/kg); however, vacuous chewing was not antagonised by SCH 23390 and NNC-756, but was blocked by BW 737C. Intense grooming was attenuated by the D-2 antagonist YM 09151 (0.005-0.5 mg/kg) while vacuous chewing was enhanced. These data suggest that intense grooming is mediated by a "D-1 like" receptor that recognises all known chemical classes of D-1-selective compounds, while vacuous chewing may be mediated by a pharmacologically distinct subtype of "D-1-like" receptor that recognises preferentially the isochromans and isoquinolines.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7862827     DOI: 10.1007/bf02244332

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  31 in total

1.  NNC-112, NNC-687 and NNC-756, new selective and highly potent dopamine D1 receptor antagonists.

Authors:  P H Andersen; F C Grønvald; R Hohlweg; L B Hansen; E Guddal; C Braestrup; E B Nielsen
Journal:  Eur J Pharmacol       Date:  1992-08-14       Impact factor: 4.432

2.  D-1 dopamine receptors and the topography of unconditioned motor behaviour: studies with the selective, 'full efficacy' benzazepine D-1 agonist SKF 83189.

Authors:  S A Daly; J L Waddington
Journal:  J Psychopharmacol       Date:  1992-01       Impact factor: 4.153

3.  Assessment of grooming and other behavioural responses to the D-1 dopamine receptor agonist SK & F 38393 and its R- and S-enantiomers in the intact adult rat.

Authors:  A G Molloy; J L Waddington
Journal:  Psychopharmacology (Berl)       Date:  1987       Impact factor: 4.530

Review 4.  Behavioural correlates of the action of selective D-1 dopamine receptor antagonists. Impact of SCH 23390 and SKF 83566, and functionally interactive D-1:D-2 receptor systems.

Authors:  J L Waddington
Journal:  Biochem Pharmacol       Date:  1986-11-01       Impact factor: 5.858

5.  Induction of oral dyskinesias in naive rats by D1 stimulation.

Authors:  H Rosengarten; J W Schweitzer; A J Friedhoff
Journal:  Life Sci       Date:  1983-12-19       Impact factor: 5.037

6.  Dopaminergic behaviour stereospecific promoted by the D1 agonist R-SK & F 38393 and selectively blocked by the D1 antagonist SCH 23390.

Authors:  A G Molloy; J L Waddington
Journal:  Psychopharmacology (Berl)       Date:  1984       Impact factor: 4.530

Review 7.  Dopamine receptor subtypes: beyond the D1/D2 classification.

Authors:  P H Andersen; J A Gingrich; M D Bates; A Dearry; P Falardeau; S E Senogles; M G Caron
Journal:  Trends Pharmacol Sci       Date:  1990-06       Impact factor: 14.819

8.  Agonist and antagonist properties of benzazepine and thienopyridine derivatives at the D1 dopamine receptor.

Authors:  K M O'Boyle; D E Gaitanopoulos; M Brenner; J L Waddington
Journal:  Neuropharmacology       Date:  1989-04       Impact factor: 5.250

9.  Selective dopamine D2 receptor reduction enhances a D1-mediated oral dyskinesia in rats.

Authors:  H Rosengarten; J W Schweitzer; A J Friedhoff
Journal:  Life Sci       Date:  1986-07-07       Impact factor: 5.037

10.  A comparison of the selectivities of SCH 23390 with BW737C89 for D1, D2 and 5-HT2 binding sites both in vitro and in vivo.

Authors:  D R Riddall
Journal:  Eur J Pharmacol       Date:  1992-01-21       Impact factor: 4.432

View more
  8 in total

Review 1.  Phenotypic studies on dopamine receptor subtype and associated signal transduction mutants: insights and challenges from 10 years at the psychopharmacology-molecular biology interface.

Authors:  John L Waddington; Colm O'Tuathaigh; Gerard O'Sullivan; Katsunori Tomiyama; Noriaki Koshikawa; David T Croke
Journal:  Psychopharmacology (Berl)       Date:  2005-09-29       Impact factor: 4.530

2.  Pharmacological characterization of behavioural responses to SK&F 83959 in relation to 'D1-like' dopamine receptors not linked to adenylyl cyclase.

Authors:  A M Deveney; J L Waddington
Journal:  Br J Pharmacol       Date:  1995-10       Impact factor: 8.739

Review 3.  Movement disorders: neurodevelopment and neurobehavioural expression.

Authors:  T Archer; R J Beninger
Journal:  J Neural Transm (Vienna)       Date:  2006-10-06       Impact factor: 3.575

4.  D1A, D1B, and D1C dopamine receptors from Xenopus laevis.

Authors:  K S Sugamori; L L Demchyshyn; M Chung; H B Niznik
Journal:  Proc Natl Acad Sci U S A       Date:  1994-10-25       Impact factor: 11.205

5.  Comparison of the new atypical antipsychotics olanzapine and ICI 204,636 with clozapine on behavioural responses to the selective "D1-like" dopamine receptor agonist A 68930 and selective "D2-like" agonist RU 24213.

Authors:  A M Deveney; J L Waddington
Journal:  Psychopharmacology (Berl)       Date:  1996-03       Impact factor: 4.530

6.  The effects of clozapine on behavioural responses to the selective 'D1-like' dopamine receptor agonist, A 68930, and to the selective 'D2-like' agonist, RU 24213.

Authors:  S A Daly; J L Waddington
Journal:  Br J Pharmacol       Date:  1994-11       Impact factor: 8.739

7.  Selective dopamine antagonist pretreatment on the antiparkinsonian effects of benzazepine D1 dopamine agonists in rodent and primate models of Parkinson's disease--the differential effects of D1 dopamine antagonists in the primate.

Authors:  K K Gnanalingham; A J Hunter; P Jenner; C D Marsden
Journal:  Psychopharmacology (Berl)       Date:  1995-02       Impact factor: 4.530

8.  The discriminative properties of the D1 dopamine agonist dihydrexidine in the rat.

Authors:  M D Schechter
Journal:  Psychopharmacology (Berl)       Date:  1995-05       Impact factor: 4.530

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.